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COMBINATORIAL GENOMIC DATA REFUTE THE HUMAN CHROMOSOME 2 
EVOLUTIONARY FUSION AND BUILD A MODEL OF FUNCTIONAL DESIGN FOR 
INTERSTITIAL TELOMERIC REPEATS
Jeffrey P. Tomkins,  Institute for Creation Research, 1806 Royal Ln Dallas, TX 75010  jtomkins@icr.org
ABSTRACT
Evolutionists allege that human chromosome 2 is the product of an ancient fusion event in an ancient hominid 
ancestor descended from apes.  However, both the alleged site of fusion and the so-called cryptic centromere of 
human chromosome 2 are situated inside active genes negating the idea of fusion.  Not only are the alleged genomic 
fossils of fusion representative of functional intragenic sequence, but they are also both highly degenerate versions 
of their supposed evolutionary beginnings, suggesting something other than an evolutionary origin.  Given that these 
data strongly refute an evolutionary fusion scenario, it behooves creationists to propose an alternative model for the 
functional nature of telomere-like sequences scattered around the internal regions of human chromosomes.  Towards 
this end, new data based on ENOCODE project data sets is provided that further elucidates the regulatory role of 
interstitial telomeric repeat sequences genome-wide, particularly with respect to their transcription factor binding 
domain properties and transcription start site associations.
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INTRODUCTION
One of the most often used arguments explaining human evolution 
from a chimpanzee-like ancestor is the alleged fusion of ape 
chromosomes 2A and 2B in a telomere-to-telomere fashion, 
resulting in human chromosome 2 (Yunis and Prakash 1982; Ijdo 
et al. 1991). This scenario attempts to account for the discrepancy 
in chromosome numbers between humans and great apes. Humans 
have a diploid chromosome complement of 46 while chimpanzees, 
orangutans, and gorillas have 48. See Figure 1 for a graphical 
depiction of the purported fusion event.
The idea of human chromosome 2 fusion is strongly promoted 
despite the fact that all known chromosome fusion events in 
extant mammals involve satellite DNA and breaks at or near 
centromeres (Chaves et al. 2003; Tsipouri et al. 2008; Adega et al. 
2009).  All genetic data in living mammals up to this point shows 
that telomere-satelliteDNA or satelliteDNA-satelliteDNA are the 
hallmark signatures of naturally occurring but rare chromosomal 
fusion sites in nature, not telomere-telomere fusions (Chaves et al. 
2003; Tsipouri et al. 2008; Adega et al. 2009).  Some evolutionists 
may counter this data with the argument that telomere-telomere 
fusions have been observed in the rearranged aberrant genomes of 
human cancer cells. However, these genomic aberrations are not 
indicative of normal healthy cells, but instead are the products of 
the failure of mechanisms maintaining genomic integrity in cells - 
leading to disease and death of the organism (Tanaka et al. 2012; 
Tanaka et al. 2014; Tu et al. 2015). 
An end-to-end fusion of chromosomes as proposed by evolutionists 
for humans would give a head-to-head telomeric repeat signature of 
at least 10,000 bases in length due to the fact that human telomeres 
range in size between 5,000 and 15,000 bases in length  (Tomkins 
and Bergman 2011a, b).  However, the alleged the fusion site is 
exceptionally small in size and only 798 bases in length. Another 
significant aspect questioning the validity of a telomere-telomere 
fusion signature is the fact that in evolutionary terms, it is very 
degenerate given the alleged 3 to 6 million years of divergence 
from a human-chimpanzee common ancestor (Fan et al. 2002). 
Given that no major rearrangements within the fusion site appear 
to have occurred combined with the lack of transposable element 
insertions, the fusion site should be about 98.5% similar to pristine 
fused repeats based on standard evolutionary predictions.  However, 
the 798-base fusion signature is only 70% identical to the sequence 
of a hypothetical pristine fusion of the same size based on a pair-
wise global alignment in the Geneious software package. 
Some evolutionists may also attempt to claim that the fusion site 
and the alleged cryptic centromere are positioned where one might 
expect them to be if a fusion occurred. However, an analysis of 
the assembled chimpanzee DNA sequences for these chromosomes 
(panTro4) reveals that not only are they assembled using human 
chromosome 2 as a scaffold, but they contain many gaps and are 
full of large numbers of meaningless N’s (Tomkins 2017). The 
letter N is substituted for nucleotides in the areas of DNA that 
contain unknown sequence instead of the letters A, T, G, or C and 
the number of N’s inserted does not correspond to actual gap sizes, 
which are unknown. At the time of this research, the new panTro5 
version of the chimpanzee genome was released and is currently in 
Figure 1. Depiction of the evolutionary model in which chimpanzee-
like chromosomes 2A and 2B allegedly fused end-to-end to form human 
chromosome 2. Chromosomes are drawn to scale according to cytogenetic 
images in Yunis and Prakash (1982).
the process of being compared by this author to the current hg38 
version of the human genome, end-trimmed trace reads, and the 
previous panTro4 version of chimpanzee.  While the new assembly 
is likely to be greatly improved, it’s veracity as an unbiased 
construction needs to be critically evaluated given the history of 
human evolutionary bias in previous versions.
While all of this information is important to consider when 
examining the plausibility of the fusion model, the most compelling 
data refuting it came when the actual fusion signature was analyzed 
in 2013 showing that it’s DNA sequence when read in the minus 
strand orientation is a functional transcription factor binding 
domain inside the first intron of the DDX11L2 noncoding RNA 
helicase, where it acts as a second promoter (Tomkins 2013; Figure 
2).  This data was further verified in a follow-up research report 
which revealed that the alleged fusion site binds to 11 different 
transcription factors, including RNA polymerase II, the primary 
enzyme that transcribes genes (Tomkins 2017).  See Figure 3 
showing ENCODE-related data from the UCSC genome browser. 
Additional data presented in the Tomkins 2017 paper showed that 
along with RNA polymerase binding, is the fact that transcription 
initiates inside the fusion-like sequence in a classic promoter-like 
expression pattern (Figure 4).  As expected, these data implicating 
promotor activity also intersect with transcriptionally active 
histone marks and active chromatin profiles that are key features of 
gene promoters. As a whole, these combinatorial results strongly 
indicate that the alleged fusion sequence is a gene promoter, not a 
random accident of chromosomal fusion. 
When the products of the DDX11L2 gene were analyzed, it 
was found that it encoded RNA transcripts expressed in at least 
255 different cell and/or tissue types (Tomkins 2013). The gene 
produces RNAs of two different lengths—short variants (~1,700 
bases long) and long variants (~2,200 bases long). The alleged 
fusion site functions as a promoter for the shorter variants (Figure 
2).  Annotation of the transcripts revealed that they contained the 
capacity for complex post-transcriptional regulation through a 
variety of microRNA binding sites (Tomkins 2013).  A number 
of the microRNA binding sites were shared with DDX11 protein 
coding gene transcripts (Tomkins 2013).  Both the DDX11L2 and 
DDX11 genes are significantly co-expressed together in the same 
tissues (Tomkins 2013).  Shared microRNA binding sites and co-
expression suggest co-regulation between a protein coding gene 
and its noncoding RNA pseudogene counterpart, as revealed in the 
well-documented example of the PTEN protein coding gene and 
it’s PTEN pseudogene counterpart (Johnsson et al. 2013).
If two chromosomes actually fused, then there would be two 
centromeres present and one of them would have to be deactivated 
to maintain chromosome stability.  Centromeres are specific regions 
of chromosomes that play an important role in the assembly of the 
kinetochore—a complex structure that plays a key function in the 
separation of chromosomes during cell division. Evolutionists 
propose that an inactivated centromere in a post-fusion scenario 
would degrade over time and become a cryptic genomic fossil, 
such as that which is alleged to be present on human chromosome 
2.
A recent research report was published seemingly bolstering the 
evidence of a cryptic centromere in human chromosome 2 (Miga 
2016). The author argues this point based on gene synteny (gene 
order) between human and chimpanzee.  Of course, the problem 
with this premise is based on the artificially contrived assembly 
of chimpanzee chromosomes 2A and B which are bloated with 
gaps and assembled based on the human genome. Using an 
argument based on synteny is fallacious because the conclusion 
is assumed in the premise.  Actual synteny between human and 
chimpanzee remains to be resolved until an unbiased assembly of 
the chimpanzee genome is produced.
A problem with the alleged cryptic centromere is that its human 
alphoid repeat DNA sequence does not closely match chimpanzee 
centromeres and chromosomes (Archidiacono et al. 1995; Haaf 
and Willard 1997; Tomkins 2017).  In addition to the problem of 
discontinuity with ape sequence, the alleged cryptic centromere 
is exceptionally small compared to a real centromere. It is only 
41,608 bases in length, but this length includes non-centromeric 
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Figure 2. Simplified illustration of the alleged fusion site inside the second intron of the DDX11L2 noncoding RNA gene. The graphic also shows 
two versions of short and long transcript variants produced along with areas of transcription factor binding. Arrow in first exon depicts direction of 
transcription.
insertions of two retroelements: a LPA3/LINE repeat (5,957 bases) 
and a SVA-E element (2,571 bases) (Figure 5).  When we subtract 
the insertions of these non-centromeric elements, it gives a length 
of only 33,080 bases which is a fraction of the size of  normal 
human centromeres that range in length between 250,000 and 
5,000,000 bases (Aldrup-Macdonald and Sullivan 2014).
However, the most serious problem with the concept of a cryptic 
centromere is that it is entirely situated inside the protein coding 
gene ANKRD30BL [Ankyrin Repeat Domain 30B Like] (Tomkins 
2017). Interestingly, the alleged cryptic centromere sequence 
extends across intron and exon regions of the gene with part of it 
actually coding for amino acids in the resulting protein (Figure 5). 
This type of ankyrin repeat protein is associated with the plasma 
membrane in eukaryotic cells and is implicated in the interaction 
of the cytoskeleton with integral membrane proteins. (Voronin and 
Kiseleva 2008).  The fact that the alleged cryptic centromere is a 
functional region inside a protein coding gene is at odds with the 
idea that it is a defunct centromere.
Not only are both the alleged fusion and cryptic centromere sites 
questionable in their sequence as to being evolutionarily derived 
from their hypothesized precursors, they both represent functional 
intragenic sequence.  Given this fusion-negating scenario, it 
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Figure 4. Transcription start site data taken from the FANTOM4, FANTOM5, and ENCODE cap analysis of gene expression (CAGE) databases for 
the genomic coordinates of the alleged 798 base fusion site (http://fantom.gsc.riken.jp).
Figure 3. UCSC genome browser (https://genome.ucsc.edu) view of the DDX11L2 gene, its aligned mRNAs, transcription factor binding, and 
transcriptionally active histone tracks in relation to the alleged fusion site.
behooves both creationist and secular researchers to investigate 
alternative functions for the types of sequence motifs involved, 
particularly the alleged fusion site sequence, which is the chief 
hallmark of the whole fusion-based evolutionary story. 
The characterization of interstitial telomeric-like repeats across 
the human genome has been documented in previous reports 
using both cytogenetic and bioinformatic techniques (Azzalin et 
al. 2001; Nergadze et al. 2007; Lin and Yan 2008; Ruiz-Herrera 
et al. 2008; Bolzan 2017).  Based on the evolutionary assumption 
that the genome is littered with the non-functional remnants of 
stochastic evolutionary processes, very little research has been 
done to investigate whether interstitial telomeric-like sites, like 
those at the alleged fusion site, might actually serve some useful 
purpose. Most research has focused on the evolutionary origins 
of interstitial telomeric repeats being accidentally and randomly 
transferred from chromosome ends along with the possibility 
that the sites of these alleged events might be associated with 
chromosome instability and disease (Nergadze et al. 2007; Lin and 
Yan 2008; Ruiz-Herrera et al. 2008; Bolzan 2017).  However, such 
research has been inconclusive as to the definitive association of 
these types of sites with human disease (Bolzan 2017).  In light 
of over a decade of inconclusive research related to attempts at 
associating interstitial telomeric-like repeats with chromosome 
instability and disease, one evolutionary researcher stated, “future 
research should focus on the possible biological significance of 
ITSs by investigating the role of these telomeric-like sequences in 
the regulation of gene expression” (Bolzan 2017).  In light of the 
research I have uncovered regarding the role of the alleged fusion 
site in the regulation of gene expression, this statement could not 
be more timely or profound.
Towards identifying the possibility of interstitial telomeric-like 
repeats having purpose and function within a creation model, like 
those found at the alleged fusion site, I have completed a research 
project which involves identifying both intact and degenerate 
telomeric-like repeats within the internal regions of human 
chromosomes and then intersecting their genomic coordinates with 
a wide variety of ENCODE project data sets. These results will help 
build a creationist model of designed and engineered functionality 
for interstitial telomeric repeats.
METHODS
The GRCh38 version of the human genome was downloaded at ftp://
ftp.ensembl.org/pub/release-90/fasta/homo_sapiens/dna/. Each of 
the chromosome FASTA files were manually end-trimmed in a text 
editor to remove telomeric sequence from both chromosome ends. 
Perfect interstitial telomeric motifs (TTAGGG and CCCTAA) 
of two tandem repeats or more were identified and binned by 
chromosome. The common degenerate telomeric forms of the motif 
(TTNGGG and CCCNAA) were also identified in tandem repeats 
of two or more and binned by chromosome. Data was outputted 
in bed file format containing data columns of chromosome ID, 
genome coordinates, feature ID (eg. forward telomere, reverse 
telomere).  Based on genomic coordinates, each identified telomeric 
repeat was then intersected with a variety of ENCODE data sets: 
gencode v. 22 gene annotation (www.gencodegenes.org), human 
lincRNAs (long intergenic noncoding RNA) genes from hg38 
(https://genome.ucsc.edu/cgi-bin/hgTracks?db=hg38), lincRNAs 
from a publication (Hangauer et al. 2013),  robust enhancers, 
permissive enhancers, ubiquitous enhancers, transcription start 
site association enhancers (http://enhancer.binf.ku.dk/presets/), 
remap transcription factor binding (http://tagc.univ-mrs.fr/remap/
index.php?page=download), and the trusight inherited disease 
loci (https://support.illumina.com/downloads/trusight_inherited_
disease_product_files.html).  ENCODE-related BED files based 
on previous versions of the human genome (e.g. hg16 and hg18) 
were converted to GRCh38 coordinates using the Python program 
CrossMap and the appropriate liftover chain conversion files (http://
crossmap.sourceforge.net). Multiple hits to the same ENCODE-
related target bed file were reduced to a single unique output hit to 
remove redundancy produced by multiple overlapping telomeric 
repeats at a single locus. Python scripts and modules written by 
author Tomkins for locating and intersecting interstitial telomeric 
sequence  can be viewed and/or downloaded at https://github.com/
jt-icr/interstitial_telomeric_repeats. 
RESULTS
In this current study, I have queried the entire interstitial space 
of the latest version of the human genome (hg38) using a Python 
module I wrote for the identification of perfect and degenerate 
interstitial telomeric sequence (ITS) sites comprising signatures of 
2 repeats or larger. These ITS sites were then intersected using their 
genome coordinates with a wide variety of ENCODE-related data 
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Figure 5. The 41,608 base cryptic centromere region on chromosome 2 that is positioned within the ANKRD30BL protein coding gene.
sets described as follows. 
The full Gencode22 data set used in this study contains all 
comprehensive protein coding gene annotations, all comprehensive 
lncRNA gene annotations, all polyA features (polyA_signal, 
polyA_site, pseudo_polyA), 2-way consensus (retrotransposed) 
pseudogenes, and tRNA genes (Derrien et al. 2012). In total, there 
are 195,178 genic features and their corresponding coordinates 
in the BED file used for intersecting ITS sites (Table 1). 
Approximately 2.7% of these genic features contained at least one 
ITS site of 2 repeats or more. Over 5,000 ITS sites of two repeats or 
larger intersected with these various Gencode22 annotations.
Long intergenic noncoding RNAs (lincRNA) are long noncoding 
RNA genes located in the intergenic protein space in the genome. 
Like lncRNA genes, lincRNA genes have complex promoters, are 
alternatively spliced and transcribed and tend to be highly cell-
type specific in their expression patterns (Ulitsky and Bartel 2013). 
They comprise a hotly pursued area of biomedical research due 
to their association with human health and cellular development 
(Guttman et al. 2011; Ulitsky et al. 2011; Batista and Chang 2013). 
Two different lincRNA datasets were queried: the UCSC lincRNAs 
and a much larger lincRNA dataset from a publication by Hangauer 
et al. (2013) which produced 730 and 300 ITS site intersections, 
respectively (Table 1).
Enhancer regions in the genome regulate the proper temporal and 
cell type specific activation of gene expression in higher eukaryotes 
(Dickel et al. 2013; Andersson et al. 2014).  Both transcription factor 
binding and transcription start sites are hallmarks of enhancers. 
Two data sets of enhancers were used in this study. Robust 
enhancers are transcribed at a significant expression level in at 
least one primary cell or tissue sample while all known transcribed 
enhancers comprise the permissive set, producing numbers of ITS 
intersections of 63 and 64, respectively (Table 1). 
Transcription start site associations (TSS) are defined as TSSs that 
correlate with transcriptional, epigenetic, and transcription factor 
binding within 500 kb of the TSS (Andersson et al. 2014). The 
goal of such research is to link enhancers to their target genes. 
Therefore, a dataset of 64,621 enhancer TSS associations was 
queried with the ITS sites in which 5,002 intersections were found 
(Table 1). A surprisingly large 8% of these TSS associated regions 
intersected with ITS sites. 
Transcription factor binding sites are determined via the biochemical 
association (binding) of transcription factors to genomic DNA 
sequence (Furey 2012; Mundade et al. 2014).  A comprehensive 
data set of transcription factor binding sites comprising 8.8 million 
genomic locations across the human genome (Griffon et al. 2015) 
was queried with ITS site resulting in 4,489 intersections. 
Given that much of the evolutionary speculation surrounding 
the implications of ITS sites as being chromosomal aberrations 
and playing a role in chromosome breakage and human disease, 
I also decided to determine if they could be associated with 
known heritable disease.  Therefore, a dataset of 8,801 inherited 
disease loci developed by the Illumina Corporation and used in 
the screening of human disease (Kingsmore 2012; Saunders et 
al. 2012) was queried with the ITS sites. The database contains 
550 genes, including coding exons, intron-exon boundaries, and 
regions harboring pathogenic mutations. Only 5 ITS sites could be 
intersected with disease related loci, and they were all degenerate 
ITS of 12 bases in length. This does not implicate them as being 
a part of the pathology of the locus, but that they were found in 
these genomic segments.  Interestingly, all five were located in 
exons of protein coding genes. One ITS site was located in the 
last exon of the peroxisomal biogenesis factor 10 (PEX10) gene 
on chromosome 1. A second was located in the last exon of the 
alkylglycerone phosphate synthase (AGPS) gene on chromosome 
2. A third was located in the last exon of the desmoplakin (DSP) 
gene on chromosome 6. A fourth was located in the last exon of the 
tripeptidyl peptidase 1 (TPP1) gene on chromosome 11. The fifth 
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Data set Number data set entries
Number 
perfect 
TTAGGG 
intersections
Number
Degenerate 
TTNGGG 
intersections
Number 
perfect 
CCCTAA 
intersections
Number
Degenerate 
CCCNAA 
intersections
Total ITS 
intersections
Gencode22 195,178 258 2,347 249 2,343 5,197
UCSC lincRNAs 21,131 59 299 85 287 730
lincRNAs from Hangauer et 
al. (2013) 59,177 6 138 26 130 300
Permissive enhancers 42,888 3 24 3 34 64
Robust enhancers 38,443 3 23 3 34 63
Enhancer transcription start 
site associated regions 64,621 204 2,242 258 2,298 5,002
Remap transcription factor 
binding 8,822,477 498 1,740 445 1,806 4,489
Tru-sight inherited disease 8,801 0 4 0 1 5
Table 1. Results from the intersection of genome-wide ITS sites two repeats or larger with various ENCODE-related data sets.
was located in a central exon of the huge 25-exon NPC Intracellular 
Cholesterol Transporter 1 (NPC1) gene on chromosome 18.
DISCUSSION
Since my original 2013 publication evaluating the genomic 
evidence for fusion, the data refuting the chromosome 2 fusion 
hypothesis have become even more compelling.  The alleged 
fusion site is clearly a functional second promoter in the second 
intron of the DDX11L2 gene (Tomkins 2013) and the alleged 
cryptic centromere site is a key sequence within the protein coding 
gene ANKRD30BL covering both intronic and exonic sequence 
(Tomkins 2017). 
While the sequence of the alleged cryptic centromere is a unique 
coding and noncoding part of a large protein coding gene, the 
alleged fusion site represents a regulatory sequence that could have 
implications for the genomic mystery of ITS sites genome-wide. 
This question also has key importance for building the creation 
model of purpose and design within the human genome.
The presence and preponderance of interstitial telomeric-like 
repeats in the human genome has been well established by a variety 
of cytogenetic and bioinformatics techniques (Azzalin et al. 2001; 
Nergadze et al. 2007; Lin and Yan 2008; Ruiz-Herrera et al. 2008; 
Bolzan 2017).  However, little is known of their possible function 
and most research has primarily focused on their evolutionary 
origins and the possibility that they might be associated with 
chromosome instability and disease.  Because of these past 
research efforts based on the evolutionary presupposition that 
the genome is littered with the remnants of purposeless random 
evolution, no research has been done to investigate whether ITS 
sites might actually serve some functional purpose. Interestingly, 
a recent review by Bolzan (2017) from a naturalistic perspective 
on ITS sites stated, “future research should focus on the possible 
biological significance of ITSs by investigating the role of these 
telomeric-like sequences in the regulation of gene expression”.  
Thus, the purpose of this paper was not to prove that ITS sites are 
abundant in the human genome, a fact already well established, but 
to ascertain what their role might be based on the premise that the 
genome was created with function and purpose, although subject to 
degeneration over time, a process commonly referred to as genetic 
entropy (Sanford 2010).
The most important finding of this current research was the 
confirmation of the possible role of ITS sites in gene regulation as 
depicted by the high numbers of ITS sites associated with enhancer 
transcription start site associated regions and transcription factor 
binding.  In addition, the same approximate number of intersections 
(~5,000) were also associated with Gencode22 annotations. These 
data closely follow the results from the comprehensive analysis of 
the alleged fusion site I conducted in two previous reports (Tomkins 
2013; Tomkins 2017) and strongly suggest that many ITS sites are 
involved in gene regulation, especially in regard to their role in 
transcription factor binding and transcription start site activity.
Another interesting minor aspect to this study was the investigation 
of the five intersections of ITS sites with inherited disease loci. 
Amazingly, all five ITS were located in the exons of protein coding 
genes.  Many exons not only code for proteins, but have also been 
found to contain gene regulatory sequence in addition to other 
imbedded codes that regulate both transcription and translation 
(Tomkins 2015).
CONCLUSION
As a key component of the evolution paradigm, scientists have 
argued that human chromosome 2 is the product of an ancient 
fusion event in a hominid ancestor following the divergence of 
humans and apes based on the alleged genomic remnants of a 
fusion event.  These telomeric-like genomic signatures are thought 
to represent the actual fusion site and a cryptic centromere. Recent 
genomic data, however, indicates that both the alleged site of 
fusion and the cryptic centromere of human chromosome 2 are 
positioned inside functional genes. Furthermore, the alleged site of 
fusion has been proven to be a functional promoter in the second 
intron of a noncoding RNA gene. Given that these data strongly 
refute evolutionary claims, this current study was undertaken to 
help develop an alternative creationist model of intelligent design 
based on the idea that these features are functional characteristics of 
unique engineering by the Creator. By comprehensively intersecting 
interstitial telomeric repeats genome-wide with ENCODE-related 
data sets, this study helps elucidate the regulatory role of interstitial 
telomeric repeat sequences, particularly with respect to their 
transcription factor binding domain properties and transcription 
start site associations.
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